shutterstock_1295341387-tartila
Tartilla / Shutterstock.com
29 May 2019Biotechnology

BGI takes Illumina to court over patent infringement in US

A subsidiary of China-based genome sequencing company BGI has filed a patent infringement suit against a US competitor.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
2 January 2019   Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
Americas
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.

More on this story

Americas
2 January 2019   Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
Americas
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.

More on this story

Americas
2 January 2019   Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.
Americas
2 July 2019   Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.
Big Pharma
4 October 2019   A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.